TNFRSF4 and central nervous system cancer: Another monoclonal antibody-based tracer was developed for immuno-PET imaging of T-cell activation targeting the costimulatory receptor OX40, and used to monitor the stimulated T-cell response in a murine orthotopic glioma model [116].